In This Issue.
- Published in:
- International Immunology, 2020, v. 32, n. 8, p. 495, doi. 10.1093/intimm/dxaa044
- Publication type:
- Article
Works matching IS 09538178 AND DT 2020 AND VI 32 AND IP 8
Results: 7
1
2
Impaired mucociliary motility enhances antigen-specific nasal IgA immune responses to a cholera toxin-based nasal vaccine.
- Published in:
- International Immunology, 2020, v. 32, n. 8, p. 559, doi. 10.1093/intimm/dxaa029
- By:
- Publication type:
- Article
3
Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease.
- Published in:
- International Immunology, 2020, v. 32, n. 8, p. 547, doi. 10.1093/intimm/dxaa022
- By:
- Publication type:
- Article
4
Citrullinated fibrinogen is a target of auto-antibodies in interstitial lung disease in mice with collagen-induced arthritis.
- Published in:
- International Immunology, 2020, v. 32, n. 8, p. 533, doi. 10.1093/intimm/dxaa021
- By:
- Publication type:
- Article
5
PD-L1 is induced on the hepatocyte surface via CKLF-like MARVEL transmembrane domain-containing protein 6 up-regulation by the anti-HBV drug Entecavir.
- Published in:
- International Immunology, 2020, v. 32, n. 8, p. 519, doi. 10.1093/intimm/dxaa018
- By:
- Publication type:
- Article
6
Tolerogenic properties of CD206<sup>+</sup> macrophages appeared in the sublingual mucosa after repeated antigen-painting.
- Published in:
- International Immunology, 2020, v. 32, n. 8, p. 509, doi. 10.1093/intimm/dxaa014
- By:
- Publication type:
- Article
7
Repurposing the psoriasis drug Oxarol to an ointment adjuvant for the influenza vaccine.
- Published in:
- International Immunology, 2020, v. 32, n. 8, p. 499, doi. 10.1093/intimm/dxaa012
- By:
- Publication type:
- Article